MiR-150-5p Overexpression in Triple-Negative Breast Cancer Contributes to the In Vitro Aggressiveness of This Breast Cancer Subtype
MiR-150-5p is frequently deregulated in cancer, with expression and mode of action varying according to the tumor type. Here, we investigated the expression levels and role of miR-150-5p in the aggressive breast cancer subtype triple-negative breast cancer (TNBC). MiR-150-5p expression levels were a...
Main Authors: | Aneja, R. (Author), Cavalli, I.J (Author), Cavalli, L.R (Author), Fonseca, A.S (Author), Kallakury, B. (Author), Ribeiro, E.M.S.F (Author), Rodriguez, Y. (Author), Souza, E.N (Author), Sugita, B.M (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI
2022
|
Subjects: | |
Online Access: | View Fulltext in Publisher |
Similar Items
-
Current Triple-Negative Breast Cancer Subtypes: Dissecting the Most Aggressive Form of Breast Cancer
by: Miquel Ensenyat-Mendez, et al.
Published: (2021-06-01) -
Cisplatin-resistant triple-negative breast cancer subtypes: multiple mechanisms of resistance
by: David P. Hill, et al.
Published: (2019-11-01) -
Metastatic Triple Negative Breast Cancer: The New Era of Thinking
by: Mohammed Amrallah A., et al.
Published: (2021-05-01) -
A Machine Learning Model to Predict the Triple Negative Breast Cancer Immune Subtype
by: Zihao Chen, et al.
Published: (2021-09-01) -
Precision Medicine and Triple-Negative Breast Cancer: Current Landscape and Future Directions
by: Fokhrul Hossain, et al.
Published: (2021-07-01)